SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma

The current lack of cancer stem cell (CSC) markers that are easily evaluated by blood samples prevents the establishment of new therapeutic strategies in hepatocellular carcinoma (HCC). Herein, we examined whether sex determining region Y-box 9 (SOX9) represents a new CSC marker, and whether osteopo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawai, Takayuki, Yasuchika, Kentaro, Ishii, Takamichi, Miyauchi, Yuya, Kojima, Hidenobu, Yamaoka, Ryoya, Katayama, Hokahiro, Yoshitoshi, Elena Yukie, Ogiso, Satoshi, Kita, Sadahiko, Yasuda, Katsutaro, Fukumitsu, Ken, Komori, Junji, Hatano, Etsuro, Kawaguchi, Yoshiya, Uemoto, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960550/
https://www.ncbi.nlm.nih.gov/pubmed/27457505
http://dx.doi.org/10.1038/srep30489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960550/
https://www.ncbi.nlm.nih.gov/pubmed/27457505
http://dx.doi.org/10.1038/srep30489

Ejemplares similares